Archive for December, 2010

New regenerative medicine centre announced by Canadian government

Author: Stem Cell Network, 12/29/10

Earlier this month, the Honourable Tony Clement, Minister of Industry, announced the establishment of the Centre for the Commercialization of Regenerative Medicine (CCRM) with a $15 million initial investment. The CCRM will be based in Toronto and is one of five new CECR’s funded through the Networks of Centres of Excellence program. While stem cell…Read more

The buzz about innovation

Author: Paul Krzyzanowski, 12/20/10

Basic scientific research is a fundamental driver of improved quality of life that our society enjoys. However, it’s tacitly acknowledged that the benefits of research sometimes don’t materialize until some time has passed, with the finish line sometimes decades away. This length of time for an advance to be recognized as ‘valuable’ is extremely unpredictable…Read more

Trending topics in hematology: summary of the 2010 American Society of Hematology conference

Author: Michelle Ly, 12/20/10

Stem cells were high on the list of hot topics at this year’s American Society of Hematology conference in Orlando, Florida, particularly regarding the uses and effects of stem cells in the treatment of disease. The Ham-Wasserman lecture, named for two past ASH presidents, was presented by Tsvee Lapidot, from the Weizmann Institute in Rehovot, Israel. His lecture…Read more

US report sets out basic ethical principles for assessing emerging technologies

Author: Ubaka Ogbogu, 12/16/10

President Obama’s Commission on the Study of Bioethical Issues today released a report of its ethical investigation and recommendations for oversight of the emerging field of synthetic biology. The report responds to a charge to the Commission issued by the President in May following the announcement by the J. Craig Venter Institute of the creation…Read more

How will chemically induced pluripotent stem cells impact stem cell policy?

Author: Ubaka Ogbogu, 12/16/10

Chris Kamel’s recent post on chemically derived transcription factors for iPS cell production is very exciting for a variety of non-scientific reasons. Most notably, the innovative procedure and future improvements are likely to ease ethical, safety and legal concerns regarding the use of oncogenic transcription factors. One such concern is the possibility that Canadian law…Read more

The business of scientific research

Author: Paul Krzyzanowski, 12/14/10

One of the biggest choices graduate students and post-doctoral fellow face is whether to stay in academia or go into the business world. But what if the two weren’t really that different? Traditional advice about running a successful academic research group focuses on the development the Principal Investigator. A recent article by David A. Stone in…Read more

Chemically induced pluripotent stem cells

Author: Chris Kamel, 12/09/10

Induced pluripotent stem (iPS) cells are generally created by the expression of a small number of key genes to reprogram adult cells into an undifferentiated, pluripotent state. Because some of the transcription factors used for reprogramming are oncogenes, as well as concerns about mutagenesis due to genomic integration, scientists have been searching for improved methods…Read more

What’s next for stem cell biology: Royal Society Meeting October 2010

Author: David Kent, 12/07/10

My last post was mostly centred on the lack of openness displayed by a growing number of scientists, but failed to comment on the wonderful array of findings that were presented by world leaders in stem cell biology. The Royal Society Meeting that took place in October was definitely designed “for scientists” and the juggernauts came out…Read more

And the winner is…

Author: Stem Cell Network, 12/01/10

Of all the projects we run out of our small admin office, certainly one of the more visually compelling is the Cells I See art contest. As a side event at the Network’s scientific meeting, Cells I See usually elicits a great deal of buzz, as conference attendees speculate on what might be the winning…Read more